Daniel Gottlieb

Daniel Gottlieb is an experienced professional in venture capital and corporate development, currently serving as a Board Observer at CorFlow since July 2024. As Director at Broadview Ventures Inc. and Longview Ventures since August 2019, Daniel is responsible for investment activities, including opportunity identification, due diligence, and involvement with portfolio company boards. Additional board roles include positions with XII Medical, Cardiosense, CroiValve, and Nyra Medical. Daniel's previous experience includes a tenure as Vice President of Marketing and Corporate Development at Proteon Therapeutics, where strategic marketing and corporate development efforts contributed to the company's growth and successful IPO. Educational credentials include an MBA in General Management from The Tuck School of Business at Dartmouth and a BA in Economics and Political Science from the University of Pennsylvania.